Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Losartan in Diabetic Nephropathy
NCT06431477Phase 4Recruiting
- Sponsor
- Chong Kun Dang Holdings
- Start
- Apr 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan in diabetic nephropathy (DN), hypertension (HTN), sponsored by Chong Kun Dang Holdings. Started Apr 2023; status: recruiting.
02
Drugs
telmisartan
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT06431477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431477.